ProShare Advisors’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-17,575
| Closed | -$2.4M | – | 1827 |
|
|
2018
Q2 | $2.4M | Sell |
17,575
-1,165
| -6% | -$106K | 0.02% | 582 |
|
|
2018
Q1 | $1.48M | Sell |
18,740
-2,941
| -14% | -$217K | 0.01% | 692 |
|
|
2017
Q4 | $1.48M | Buy |
21,681
+396
| +2% | +$20.5K | 0.01% | 701 |
|
|
2017
Q3 | $856K | Buy |
21,285
+1,723
| +9% | +$66.5K | 0.01% | 772 |
|
|
2017
Q2 | $778K | Sell |
19,562
-700
| -3% | -$25.6K | 0.01% | 813 |
|
|
2017
Q1 | $653K | Sell |
20,262
-5,061
| -20% | -$126K | 0.01% | 909 |
|
|
2016
Q4 | $448K | Buy |
25,323
+1,981
| +8% | +$42.7K | 0.01% | 1135 |
|
|
2016
Q3 | $545K | Sell |
23,342
-4,060
| -15% | -$92.2K | 0.01% | 922 |
|
|
2016
Q2 | $511K | Buy |
27,402
+449
| +2% | +$8.12K | 0.01% | 957 |
|
|
2016
Q1 | $490K | Sell |
26,953
-2,488
| -8% | -$40.1K | 0.01% | 1005 |
|
|
2015
Q4 | $620K | Buy |
29,441
+2,075
| +8% | +$40K | 0.01% | 938 |
|
|
2015
Q3 | $505K | Sell |
27,366
-1,519
| -5% | -$37.9K | 0.01% | 938 |
|
|
2015
Q2 | $977K | Buy |
28,885
+3,178
| +12% | +$128K | 0.01% | 786 |
|
|
2015
Q1 | $1.24M | Buy |
25,707
+3,952
| +18% | +$179K | 0.01% | 741 |
|
|
2014
Q4 | $483K | Buy |
+21,755
| New | +$502K | 0.01% | 1218 |
|
|
2014
Q2 | – | Sell |
-6,947
| Closed | -$225K | – | 2703 |
|
|
2014
Q1 | $225K | Buy |
+6,947
| New | +$226K | ﹤0.01% | 2440 |
|
ProShare Advisors's FMI Position: Q3 2018 in Review
ProShare Advisors sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 17,575 shares — an estimated $2.4M sold.
ProShare Advisors first reported a position in FMI in Q1 2014 and held it in 16 quarters. The position peaked at $2.4M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- ProShare Advisors reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- ProShare Advisors sold 17,575 Foundation Medicine, Inc. shares in Q3 2018, an estimated $2.4M.
- ProShare Advisors first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 16 quarters.
- ProShare Advisors's Foundation Medicine, Inc. position peaked at $2.4M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on ProShare Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.